Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018)

Sintx Technologies' (SINT) quarterly Cash from Discontinued Operations came in at 882000.0 in Q4 2018, down 47.84% year-on-year from 1691000.0 in Q4 2017, and up 352.31% quarter-over-quarter from 195000.0 in Q3 2018.

Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends

Sintx Technologies' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 882000.0 for Q4 2018.

  • On a quarterly basis, Cash from Discontinued Operations fell 47.84% year-over-year to 882000.0 in Q4 2018; TTM through Dec 2018 was 675000.0, a N/A change from a year earlier, with the FY2018 full-year figure at 675000.0, down 72.42% from the prior year.
  • Cash from Discontinued Operations grew to 882000.0 in Q4 2018 per SINT's latest filing, from 195000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 1691000.0 in Q4 2017 and bottomed at 616000.0 in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Sintx Technologies 17,274.80 -1.87 Mn 144,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2018 882,000.00
Dec 31, 2018 882,000.00
Sep 30, 2018 195,000.00
Sep 30, 2018 195,000.00
Jun 30, 2018 -616,000.00
Jun 30, 2018 -616,000.00
Mar 31, 2018 214,000.00
Mar 31, 2018 214,000.00
Dec 31, 2017 1.69 Mn
Dec 31, 2017 1.69 Mn